| Optical redox ratio identifies metastatic potential-dependent changes in breast cancer cell metabolism K Alhallak, LG Rebello, TJ Muldoon, KP Quinn, N Rajaram Biomedical optics express 7 (11), 4364-4374, 2016 | 127 | 2016 |
| Targeting CD47 as a novel immunotherapy for multiple myeloma J Sun, B Muz, K Alhallak, M Markovic, S Gurley, Z Wang, N Guenthner, ... Cancers 12 (2), 305, 2020 | 78 | 2020 |
| Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma C Federico, K Alhallak, J Sun, K Duncan, F Azab, GP Sudlow, ... Nature communications 11 (1), 6037, 2020 | 69 | 2020 |
| Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma P de la Puente, MJ Luderer, C Federico, A Jin, RC Gilson, C Egbulefu, ... Journal of Controlled Release 270, 158-176, 2018 | 65 | 2018 |
| Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy K Alhallak, J Sun, K Wasden, N Guenthner, J O’Neal, B Muz, J King, ... Leukemia 35 (8), 2346-2357, 2021 | 57 | 2021 |
| Localized delivery of cisplatin to cervical cancer improves its therapeutic efficacy and minimizes its side effect profile C Federico, J Sun, B Muz, K Alhallak, PF Cosper, N Muhammad, A Jeske, ... International Journal of Radiation Oncology* Biology* Physics 109 (5), 1483-1494, 2021 | 54 | 2021 |
| Thermal sensitive liposomes improve delivery of boronated agents for boron neutron capture therapy MJ Luderer, B Muz, K Alhallak, J Sun, K Wasden, N Guenthner, ... Pharmaceutical research 36, 1-8, 2019 | 35 | 2019 |
| A Radiosensitizing Inhibitor of HIF-1 alters the Optical Redox State of Human Lung Cancer Cells In Vitro DE Lee, K Alhallak, SV Jenkins, I Vargas, NP Greene, KP Quinn, ... Scientific Reports 8 (1), 8815, 2018 | 33 | 2018 |
| Optical imaging of radiation-induced metabolic changes in radiation-sensitive and resistant cancer cells K Alhallak, SV Jenkins, DE Lee, NP Greene, KP Quinn, RJ Griffin, ... Journal of Biomedical Optics 22 (6), 060502-060502, 2017 | 31 | 2017 |
| Quantitative diffuse reflectance spectroscopy of short-term changes in tumor oxygenation after radiation in a matched model of radiation resistance PM Diaz, SV Jenkins, K Alhallak, D Semeniak, RJ Griffin, RPM Dings, ... Biomedical Optics Express 9 (8), 3794-3804, 2018 | 26 | 2018 |
| Bispecific T cell engagers for the treatment of multiple myeloma: achievements and challenges K Alhallak, J Sun, A Jeske, C Park, J Yavner, H Bash, B Lubben, ... Cancers 13 (12), 2853, 2021 | 14 | 2021 |
| A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma K Alhallak, A Jeske, P de la Puente, J Sun, M Fiala, F Azab, B Muz, ... Scientific reports 11 (1), 19343, 2021 | 11 | 2021 |
| 3D tissue engineered plasma cultures support leukemic proliferation and induces drug resistance K Alhallak, P de la Puente, A Jeske, J Sun, B Muz, MP Rettig, I Sahin, ... Leukemia & Lymphoma 62 (10), 2457-2465, 2021 | 11 | 2021 |
| Rapid quantification of mitochondrial fractal dimension in individual cells I Vargas, K Alhallak, OI Kolenc, SV Jenkins, RJ Griffin, RPM Dings, ... Biomedical Optics Express 9 (11), 5269-5279, 2018 | 11 | 2018 |
| Nanoparticle T cell engagers for the treatment of acute myeloid leukemia K Alhallak, J Sun, B Muz, A Jeske, J Yavner, H Bash, C Park, B Lubben, ... Oncotarget 12 (19), 1878, 2021 | 10 | 2021 |
| Liposomal phytohemagglutinin: In vivo T‐cell activator as a novel pan‐cancer immunotherapy K Alhallak, J Sun, B Muz, A Jeske, J O’Neal, JK Ritchey, S Achilefu, ... Journal of Cellular and Molecular Medicine 26 (3), 940-944, 2022 | 9 | 2022 |
| CXCR4-targeted PET imaging using 64Cu-AMD3100 for detection of Waldenström Macroglobulinemia B Muz, N Bandara, C Mpoy, J Sun, K Alhallak, F Azab, BE Rogers, ... Cancer biology & therapy 21 (1), 52-60, 2020 | 9 | 2020 |
| Biomaterials for cancer immunotherapy K Alhallak, J Sun, B Muz, AK Azab Biomaterials for Cancer Therapeutics, 499-526, 2020 | 7 | 2020 |
| A novel innovation and entrepreneurship (I&E) training program for biomedical research trainees JG Grailer III, K Alhallak, AL Antes, MS Kinch, L Woods, E Toker, ... Academic Medicine 97 (9), 1335-1340, 2022 | 6 | 2022 |
| T cell engaging agents and methods of use thereof AK Azab, K Alhallak US Patent App. 16/698,285, 2020 | | 2020 |
Abdel Kareem AzabAssociate Professor, Biomedical Engineering, University of Texas Southwestern Medical CenterVerified email at utsouthwestern.edu